Allarity Therapeutics, Inc. (ALLR) Free cash flow 2020–2025
Allarity Therapeutics, Inc. (ALLR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.8MFY2025 · since FY2020: -$7.3M → -$14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.8M | +16.0% |
| FY2024 | -$17.6M | -38.5% |
| FY2023 | -$12.7M | +24.3% |
| FY2022 | -$16.8M | — |
| FY2020 | -$7.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice